Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and connectivity solutions. Our mission is to improve patient outcomes and reduce the cost of care. Masimo’s breakthrough SET® pulse oximetry and rainbow® Pulse CO-Oximetry measurements, introduced in 1995 and 2005 respectively, allow accurate, reliable noninvasive and continuous monitoring in challenging conditions like motion and low perfusion, and of blood constituents that previously could only be measured invasively, like total hemoglobin (SpHb®). Powered by the Masimo Hospital Automation™ platform, Masimo automation and telehealth and telemonitoring solutions continue to improve and automate care delivery both in the hospital and beyond. From the Root® connectivity hub and Patienr SafetyNet™ remote monitoring and clinician notification system, to home-based Masimo SafetyNet® for tetherless remote patient management and the newly announced W1™ watch, Masimo continues to advance the forefront of teleheath during the pandemic and beyond, while at the same time expanding into additional measurement areas such as SedLine® and O3® brain monitoring, NomoLine® capnography, softFlow™ nasal high-flow therapy, and Bridge™ opioid symptom withdrawal therapy.